Search research articles
Contact Us
Filters
Showing results (211-220 of 226) with videos related to
Page
of 23
Sort By:
Anticancer Research
|
March 1, 1991
Inhibition of growth of HeLa cell tumours in nude mice by 125I-labeled anticytokeratin and antiPLAP monoclonal antibodies
K E Riklund, R Makiya, B Sundström, et al.
British Journal of Cancer
|
February 1, 1993
Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans
A T Bergenheim, P O Gunnarsson, K Edman, et al.
Cancer Chemotherapy and Pharmacology
|
March 6, 1998
Distribution of estramustine in the BT4C rat glioma model
M Johansson, A T Bergenheim, R D'Argy, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1994
Acute effects of accelerated radiotherapy in combination with carbogen breathing and nicotinamide (ARCON)
B Zackrisson, L Franzén, R Henriksson, et al.
Clinical Neuropathology
|
February 17, 2009
Expression of leucine-rich repeats and immunoglobulin-like domains (LRIG) proteins in human ependymoma relates to tumor location, WHO grade, and patient age
W Yi, H Haapasalo, C Holmlund, et al.
Acta Oncologica (Stockholm, Sweden)
|
May 16, 2022
Cancer in young adulthood - classifying the intensity of treatment
C Hedman, J Ahlgren, K E Smedby, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 1996
A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy
L Franzén, J Nyman, H Hagberg, et al.
Lakartidningen
|
February 12, 1998
[SBU is wrong on radiotherapy of brain tumors. Early postoperative therapy prolongs the symptom-free period]
R Henriksson, G Berg, L Andreasson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 23, 2003
Overexpression of c-erbB-2 is related to a higher expression of vascular endothelial growth factor (VEGF) and constitutes an independent prognostic factor in primary node-positive breast cancer after adjuvant systemic treatment
B Linderholm, J Andersson, B Lindh, et al.
Neoplasma
|
September 13, 2017
The prognostic value of pre-treatment thrombocytosis in two cohorts of patients with non-small cell lung cancer treated with curatively intended chemoradiotherapy
G Holgersson, S Bergstrom, A Hallqvist, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 226) with videos related to
Sort By:
Page
of 23
Anticancer Research
|
March 1, 1991
Inhibition of growth of HeLa cell tumours in nude mice by 125I-labeled anticytokeratin and antiPLAP monoclonal antibodies
K E Riklund, R Makiya, B Sundström, et al.
British Journal of Cancer
|
February 1, 1993
Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans
A T Bergenheim, P O Gunnarsson, K Edman, et al.
Cancer Chemotherapy and Pharmacology
|
March 6, 1998
Distribution of estramustine in the BT4C rat glioma model
M Johansson, A T Bergenheim, R D'Argy, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1994
Acute effects of accelerated radiotherapy in combination with carbogen breathing and nicotinamide (ARCON)
B Zackrisson, L Franzén, R Henriksson, et al.
Clinical Neuropathology
|
February 17, 2009
Expression of leucine-rich repeats and immunoglobulin-like domains (LRIG) proteins in human ependymoma relates to tumor location, WHO grade, and patient age
W Yi, H Haapasalo, C Holmlund, et al.
Acta Oncologica (Stockholm, Sweden)
|
May 16, 2022
Cancer in young adulthood - classifying the intensity of treatment
C Hedman, J Ahlgren, K E Smedby, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 1996
A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy
L Franzén, J Nyman, H Hagberg, et al.
Lakartidningen
|
February 12, 1998
[SBU is wrong on radiotherapy of brain tumors. Early postoperative therapy prolongs the symptom-free period]
R Henriksson, G Berg, L Andreasson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 23, 2003
Overexpression of c-erbB-2 is related to a higher expression of vascular endothelial growth factor (VEGF) and constitutes an independent prognostic factor in primary node-positive breast cancer after adjuvant systemic treatment
B Linderholm, J Andersson, B Lindh, et al.
Neoplasma
|
September 13, 2017
The prognostic value of pre-treatment thrombocytosis in two cohorts of patients with non-small cell lung cancer treated with curatively intended chemoradiotherapy
G Holgersson, S Bergstrom, A Hallqvist, et al.
Page
of 23